Literature DB >> 7636318

Eugene Robertson Special Lecture. Hyperthermia from the clinic to the laboratory: a hypothesis.

J R Oleson1.   

Abstract

Recently reported thermal isoeffective dose-response relationships in human tumours confirm the existence of an effect of hyperthermia in combination with radiotherapy. The prognostically important thermal doses are based upon the lowest temperatures achieved within tumours, and these thermal doses are well below those used in most laboratory studies that have provided the rational for hyperthermia treatment. Direct thermal cytotoxicity and thermal radiosensitization are insignificant at these low thermal doses. Other explanations for the mechanism of hyperthermia effect appear warranted. We hypothesize that hyperthermia at low thermal doses causes reoxygenation and hence direct radiosensitization in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636318     DOI: 10.3109/02656739509022467

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  23 in total

1.  Commentary on classic paper in hyperthermic oncology 'Tumour oxygenation is increased by hyperthermia at mild temperatures' by CW Song et al., 1996.

Authors:  Robert J Griffin; Peter M Corry
Journal:  Int J Hyperthermia       Date:  2009-03       Impact factor: 3.914

2.  Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer.

Authors:  Tamer Refaat; Sean Sachdev; Vythialinga Sathiaseelan; Irene Helenowski; Salah Abdelmoneim; Margaret C Pierce; Gayle Woloschak; William Small; Bharat Mittal; Krystyna D Kiel
Journal:  Breast       Date:  2015-04-18       Impact factor: 4.380

Review 3.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

Review 4.  Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

Authors:  Chen-Ting Lee; Thomas Mace; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 5.  Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.

Authors:  Robert J Griffin; Ruud P M Dings; Azemat Jamshidi-Parsian; Chang W Song
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

6.  Tumour pO2 can be increased markedly by mild hyperthermia.

Authors:  K Iwata; A Shakil; W J Hur; C M Makepeace; R J Griffin; C W Song
Journal:  Br J Cancer Suppl       Date:  1996-07

7.  Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Alvin T Yeh; Steen J Madsen
Journal:  J Neurooncol       Date:  2004-12       Impact factor: 4.130

Review 8.  Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial.

Authors:  B Rau; P Wust; P Hohenberger; J Löffel; M Hünerbein; C Below; J Gellermann; A Speidel; T Vogl; H Riess; R Felix; P M Schlag
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

9.  Synergistic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors.

Authors:  Jonathan G Mehtala; Sandra Torregrosa-Allen; Bennett D Elzey; Mansik Jeon; Chulhong Kim; Alexander Wei
Journal:  Nanomedicine (Lond)       Date:  2014-02-05       Impact factor: 5.307

10.  NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.

Authors:  Eui Jung Moon; Pierre Sonveaux; Paolo E Porporato; Pierre Danhier; Bernard Gallez; Ines Batinic-Haberle; Yu-Chih Nien; Thies Schroeder; Mark W Dewhirst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.